Aspire-Lakewood Holdings (ASBP) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Aspire-Lakewood Holdings (ASBP) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.00 of bullish evidence against -0.56 bearish.

Aspire-Lakewood Holdings last closed at $8.30, -3.82% on the session.

Against the IVW growth benchmark the position is -2.59% over the forecast window.

The read is built from 12 underlying insights — 0 bullish and 12 bearish.

Agreement across those insights is 100%.

19 graded predictions for ASBP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Aspire-Lakewood Holdings in the 100th percentile on return on equity, where 100 is best.

Aspire-Lakewood Holdings is classified under Health Care / Pharmaceuticals, with a market capitalisation of $12.11M.

StockMap tracks Aspire-Lakewood Holdings as the 128th largest of the 150 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 95 Neutral, 42 Moderate Underperform and 13 Moderate Outperform.

On that composite Aspire-Lakewood Holdings ranks 107th of 150 in the group, against a group median of -0.08.

Other Health Care stocks

Aspire-Lakewood Holdings (ASBP) — StockMap 2-week forecast & tracked accuracy